4//SEC Filing
Ende Eric J 4
Accession 0001493152-23-039335
CIK 0001582554other
Filed
Nov 2, 8:00 PM ET
Accepted
Nov 3, 4:49 PM ET
Size
5.7 KB
Accession
0001493152-23-039335
Insider Transaction Report
Form 4
Ende Eric J
Director
Transactions
- Award
Stock option (right to buy)
2023-11-01+437,244→ 437,244 totalExercise: $0.21Exp: 2033-11-01→ Common Stock (437,244 underlying)
Footnotes (1)
- [F1]The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). The option vests in equal monthly installments over a period of 12 months commencing on November 1, 2023. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2013 Plan.
Documents
Issuer
Matinas BioPharma Holdings, Inc.
CIK 0001582554
Entity typeother
Related Parties
1- filerCIK 0001494386
Filing Metadata
- Form type
- 4
- Filed
- Nov 2, 8:00 PM ET
- Accepted
- Nov 3, 4:49 PM ET
- Size
- 5.7 KB